NO20042542L - Anvendelse av ascomycin for behandling av blefarit - Google Patents

Anvendelse av ascomycin for behandling av blefarit

Info

Publication number: NO20042542L
Authority: NO; Norway
Prior art keywords: ascomycin; blepharitis; treatment
Prior art date: 2001-11-19

Application number

NO20042542A

Other languages

English (en)

Inventor

Mario Fsadni

Elisabeth Latour

Piotr Szczesny

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-19

Filing date

2004-06-17

Publication date

2004-06-17

2004-06-17 Application filed by Novartis Ag filed Critical Novartis Ag

2004-06-17 Publication of NO20042542L publication Critical patent/NO20042542L/no

Links

ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 title 1
ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 title 1
208000010217 blepharitis Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20042542A 2001-11-19 2004-06-17 Anvendelse av ascomycin for behandling av blefarit NO20042542L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01127546		2001-11-19
PCT/EP2002/012921 WO2003043633A1 (en)	2001-11-19	2002-11-18	Use of an ascomycin for the treatment of blepharitis

Publications (1)

Publication Number	Publication Date
NO20042542L true NO20042542L (no)	2004-06-17

Family

ID=8179285

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042542A NO20042542L (no)	2001-11-19	2004-06-17	Anvendelse av ascomycin for behandling av blefarit

Country Status (17)

Country	Link
US (2)	US20050043286A1 (no)
EP (2)	EP1450798A1 (no)
JP (1)	JP2005511633A (no)
KR (1)	KR20040066825A (no)
CN (1)	CN1589144A (no)
AU (1)	AU2002366222A1 (no)
BR (1)	BR0214244A (no)
CA (1)	CA2467549A1 (no)
HU (1)	HUP0500698A2 (no)
IL (1)	IL161849A0 (no)
MX (1)	MXPA04004757A (no)
NO (1)	NO20042542L (no)
NZ (1)	NZ532963A (no)
PL (1)	PL368642A1 (no)
RU (1)	RU2004118424A (no)
WO (1)	WO2003043633A1 (no)
ZA (1)	ZA200403575B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3741367A1 (en)	2019-05-21	2020-11-25	Premark Pharma GmbH	Treatment of ocular disease
US20220160668A1 (en)	2020-11-23	2022-05-26	Sight Sciences, Inc.	Formulations and methods for treating conditions of the eye
CN121263183A (zh)	2023-04-06	2026-01-02	普利马克制药有限责任公司	吡美莫司用于治疗患者的特征在于牛津分级量表角膜染色评分为4或5分的干眼症的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2154262T3 (es) *	1991-04-26	2001-04-01	Fujisawa Pharmaceutical Co	Uso de compuestos macrolidos para enfermedades oculares.
ZA924953B (en) *	1991-07-25	1993-04-28	Univ Louisville Res Found	Method of treating ocular inflammation
SE9904863D0 (sv) *	1999-12-30	1999-12-30	Medscand Medical Ab	New use
AR033151A1 (es) *	2001-04-12	2003-12-03	Sucampo Pharmaceuticals Inc	Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares

2002
- 2002-11-18 RU RU2004118424/15A patent/RU2004118424A/ru not_active Application Discontinuation
- 2002-11-18 CN CNA028229975A patent/CN1589144A/zh active Pending
- 2002-11-18 US US10/495,993 patent/US20050043286A1/en not_active Abandoned
- 2002-11-18 PL PL02368642A patent/PL368642A1/xx not_active Application Discontinuation
- 2002-11-18 MX MXPA04004757A patent/MXPA04004757A/es unknown
- 2002-11-18 WO PCT/EP2002/012921 patent/WO2003043633A1/en not_active Ceased
- 2002-11-18 JP JP2003545314A patent/JP2005511633A/ja active Pending
- 2002-11-18 BR BR0214244-9A patent/BR0214244A/pt not_active IP Right Cessation
- 2002-11-18 HU HU0500698A patent/HUP0500698A2/hu unknown
- 2002-11-18 EP EP02790400A patent/EP1450798A1/en not_active Withdrawn
- 2002-11-18 KR KR10-2004-7007555A patent/KR20040066825A/ko not_active Ceased
- 2002-11-18 IL IL16184902A patent/IL161849A0/xx unknown
- 2002-11-18 EP EP06123838A patent/EP1754482A1/en not_active Withdrawn
- 2002-11-18 CA CA002467549A patent/CA2467549A1/en not_active Abandoned
- 2002-11-18 AU AU2002366222A patent/AU2002366222A1/en not_active Abandoned
- 2002-11-18 NZ NZ532963A patent/NZ532963A/en unknown
2004
- 2004-05-11 ZA ZA200403575A patent/ZA200403575B/en unknown
- 2004-06-17 NO NO20042542A patent/NO20042542L/no not_active Application Discontinuation
2007
- 2007-09-04 US US11/899,155 patent/US20080076793A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL161849A0 (en)	2005-11-20
EP1754482A1 (en)	2007-02-21
PL368642A1 (en)	2005-04-04
KR20040066825A (ko)	2004-07-27
CA2467549A1 (en)	2003-05-30
US20050043286A1 (en)	2005-02-24
RU2004118424A (ru)	2005-05-10
US20080076793A1 (en)	2008-03-27
ZA200403575B (en)	2006-07-26
EP1450798A1 (en)	2004-09-01
MXPA04004757A (es)	2004-08-02
NZ532963A (en)	2007-01-26
CN1589144A (zh)	2005-03-02
BR0214244A (pt)	2004-09-21
WO2003043633A1 (en)	2003-05-30
HUP0500698A2 (en)	2006-08-28
AU2002366222A1 (en)	2003-06-10
JP2005511633A (ja)	2005-04-28

Similar Documents

Publication	Publication Date	Title
LTPA2019511I1 (lt)	2019-06-25	Rapamicino darinys, skirtas plaučių vėžio gydymui
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20040097L (no)	2004-03-01	Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20041882L (no)	2004-05-07	Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
NO20035156L (no)	2004-01-20	Fremgangsmåter for brønnbehandling
ZA200305691B (en)	2005-02-23	The use of substituted azetidione compounds for the treatment of sitosterolemia
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20042140L (no)	2004-07-22	Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
MXPA03002814A (es)	2003-10-14	Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
DK1448205T3 (da)	2011-12-12	Kombinationer til behandling af immunoinflammatoriske sygdomme
NO20034311D0 (no)	2003-09-26	CCR5-antagonister for behandling av AIDS
NO20051503D0 (no)	2005-03-21	Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
IS6917A (is)	2003-08-18	Epóþílon afleiður til meðhöndlunar erfiðra æxla
EE200300396A (et)	2003-12-15	Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviks
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
DE60218451D1 (de)	2007-04-12	15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
NO20055010D0 (no)	2005-10-27	Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
EP1626692A4 (en)	2008-12-10	COMPOUNDS FOR TREATING FLAVIVIRUS INFECTIONS
NO20034123L (no)	2003-09-16	Fremgangsmåte for behandling av brennstoff
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20024776D0 (no)	2002-10-03	Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20024777D0 (no)	2002-10-03	Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner

Legal Events

Date	Code	Title	Description
2010-06-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application